IBDEI0IX ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9228,1,3,0)
 ;;=3^90662
 ;;^UTILITY(U,$J,358.3,9229,0)
 ;;=285.9^^64^649^3
 ;;^UTILITY(U,$J,358.3,9229,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,9229,1,1,0)
 ;;=1^285.9
 ;;^UTILITY(U,$J,358.3,9229,1,2,0)
 ;;=2^ANEMIA NOS
 ;;^UTILITY(U,$J,358.3,9230,0)
 ;;=715.98^^64^649^46
 ;;^UTILITY(U,$J,358.3,9230,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,9230,1,1,0)
 ;;=1^715.98
 ;;^UTILITY(U,$J,358.3,9230,1,2,0)
 ;;=2^DJD
 ;;^UTILITY(U,$J,358.3,9231,0)
 ;;=724.2^^64^649^75
 ;;^UTILITY(U,$J,358.3,9231,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,9231,1,1,0)
 ;;=1^724.2
 ;;^UTILITY(U,$J,358.3,9231,1,2,0)
 ;;=2^LUMBAGO
 ;;^UTILITY(U,$J,358.3,9232,0)
 ;;=272.4^^64^649^62
 ;;^UTILITY(U,$J,358.3,9232,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,9232,1,1,0)
 ;;=1^272.4
 ;;^UTILITY(U,$J,358.3,9232,1,2,0)
 ;;=2^HYPERLIPIDEMIA NEC/NOS
 ;;^UTILITY(U,$J,358.3,9233,0)
 ;;=724.5^^64^649^11
 ;;^UTILITY(U,$J,358.3,9233,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,9233,1,1,0)
 ;;=1^724.5
 ;;^UTILITY(U,$J,358.3,9233,1,2,0)
 ;;=2^BACKACHE NOS
 ;;^UTILITY(U,$J,358.3,9234,0)
 ;;=702.0^^64^649^1
 ;;^UTILITY(U,$J,358.3,9234,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,9234,1,1,0)
 ;;=1^702.0
 ;;^UTILITY(U,$J,358.3,9234,1,2,0)
 ;;=2^ACTINIC KERATOSIS
 ;;^UTILITY(U,$J,358.3,9235,0)
 ;;=719.40^^64^649^74
 ;;^UTILITY(U,$J,358.3,9235,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,9235,1,1,0)
 ;;=1^719.40
 ;;^UTILITY(U,$J,358.3,9235,1,2,0)
 ;;=2^JOINT PAIN-UNSPEC
 ;;^UTILITY(U,$J,358.3,9236,0)
 ;;=380.4^^64^649^66
 ;;^UTILITY(U,$J,358.3,9236,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,9236,1,1,0)
 ;;=1^380.4
 ;;^UTILITY(U,$J,358.3,9236,1,2,0)
 ;;=2^IMPACTED CERUMEN
 ;;^UTILITY(U,$J,358.3,9237,0)
 ;;=727.3^^64^649^20
 ;;^UTILITY(U,$J,358.3,9237,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,9237,1,1,0)
 ;;=1^727.3
 ;;^UTILITY(U,$J,358.3,9237,1,2,0)
 ;;=2^BURSITIS NEC
 ;;^UTILITY(U,$J,358.3,9238,0)
 ;;=389.9^^64^649^59
 ;;^UTILITY(U,$J,358.3,9238,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,9238,1,1,0)
 ;;=1^389.9
 ;;^UTILITY(U,$J,358.3,9238,1,2,0)
 ;;=2^HEARING LOSS NOS
 ;;^UTILITY(U,$J,358.3,9239,0)
 ;;=274.9^^64^649^57
 ;;^UTILITY(U,$J,358.3,9239,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,9239,1,1,0)
 ;;=1^274.9
 ;;^UTILITY(U,$J,358.3,9239,1,2,0)
 ;;=2^GOUT NOS
 ;;^UTILITY(U,$J,358.3,9240,0)
 ;;=729.2^^64^649^79
 ;;^UTILITY(U,$J,358.3,9240,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,9240,1,1,0)
 ;;=1^729.2
 ;;^UTILITY(U,$J,358.3,9240,1,2,0)
 ;;=2^NEURALGIA/NEURITIS/RADICULITIS
 ;;^UTILITY(U,$J,358.3,9240,2)
 ;;=^82605
 ;;^UTILITY(U,$J,358.3,9241,0)
 ;;=366.9^^64^649^22
 ;;^UTILITY(U,$J,358.3,9241,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,9241,1,1,0)
 ;;=1^366.9
 ;;^UTILITY(U,$J,358.3,9241,1,2,0)
 ;;=2^CATARACT NOS
 ;;^UTILITY(U,$J,358.3,9242,0)
 ;;=278.00^^64^649^81
 ;;^UTILITY(U,$J,358.3,9242,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,9242,1,1,0)
 ;;=1^278.00
 ;;^UTILITY(U,$J,358.3,9242,1,2,0)
 ;;=2^OBESITY, UNSP
 ;;^UTILITY(U,$J,358.3,9243,0)
 ;;=365.9^^64^649^56
 ;;^UTILITY(U,$J,358.3,9243,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,9243,1,1,0)
 ;;=1^365.9
 ;;^UTILITY(U,$J,358.3,9243,1,2,0)
 ;;=2^GLAUCOMA NOS
 ;;^UTILITY(U,$J,358.3,9244,0)
 ;;=496.^^64^649^39
 ;;^UTILITY(U,$J,358.3,9244,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,9244,1,1,0)
 ;;=1^496.
 ;;^UTILITY(U,$J,358.3,9244,1,2,0)
 ;;=2^COPD
 ;;^UTILITY(U,$J,358.3,9245,0)
 ;;=437.9^^64^649^23
 ;;^UTILITY(U,$J,358.3,9245,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,9245,1,1,0)
 ;;=1^437.9
 ;;^UTILITY(U,$J,358.3,9245,1,2,0)
 ;;=2^CEREBROVASC DISEASE NOS
